Stock Futures Rally as Fed Signals End to Rate-Hike Campaign
Stock futures surged on Thursday, with investors expressing growing confidence that the Federal Reserve was nearing the conclusion of its rate-hike campaign. The Dow Jones
Home
Page 352
Stocks Surge as Federal Reserve Maintains Highest Interest Rates in 22 Years
In a significant move for the financial markets, the Federal Reserve opted to keep interest rates at their highest range in over two decades at
Benchmark 10-year Treasury Yields Hit Two-Week Lows as Fed Holds Steady on Rates
Benchmark 10-year Treasury yields dipped to their lowest levels in two weeks on Wednesday following the Federal Reserve’s decision to maintain interest rates, with a
Federal Reserve Signals Caution, Leaves Interest Rates at 22-Years Peak
In a highly anticipated move, the United States Federal Reserve announced on Wednesday its decision to maintain the benchmark interest rates within a range of
Tenon Medical Announces 1:10 Reverse Stock Split, Faces Stock Decline
In a move aimed at reshaping its financial structure, Tenon Medical, a company at the forefront of revolutionizing care for patients afflicted with specific sacroiliac
BioSig Technologies’ Stock Skyrockets Following Patent Milestone
BioSig Technologies, a leading medical technology company specializing in intracardiac signal visualization, announced a significant milestone today with the reception of multiple new utility patents
Blue Ridge Bankshares Stock Sees Sharp Decline Following Q3 Financial Report
Blue Ridge Bankshares, the parent company of Blue Ridge Bank, National Association, and BRB Financial Group, has released its financial results for the quarter ending
Precision BioSciences Stock Rally ahead of Q3 2023 Results
Precision BioSciences, a cutting-edge gene editing company specializing in innovative in vivo gene editing therapies through its proprietary ARCUS® platform, declared today its intention to
TG Therapeutics Reports Strong Q3 Results, Bolstered by BRIUMVI Success, Stock Soars
TG Therapeutics, a biopharmaceutical company, unveiled its financial results for the third quarter (Q3) ending September 30, 2023, coupled with recent company milestones, sparking a
FTC Urged to Examine Exxon Mobil, Chevron Mergers Amidst Antitrust Concerns
US Senate Majority Leader Charles Schumer has voiced apprehensions regarding the recent acquisitions of Exxon Mobil and Chevron Corp., marking them as two of the
